| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |